NCT01593371View on ClinicalTrials.gov

Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

January 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Metformin

Metformin 1000 mg fixed dose, twice daily (500 mg tablets x 2)

DRUG

Pioglitazone

Pioglitazone 30 mg fixed dose, twice daily (15 mg tablets x 2)

Trial Locations (1)

13145-784

Tehran University of Medical Sciences, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01593371 - Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter